https://www.avient.com/sites/default/files/2021-06/cedula-avient.pdf
Art. 23 N° 1 D.L. 825 Ley de IVA.
https://www.avient.com/sites/default/files/2023-10/ISO 22000 Certificate.pdf
Certificate Number:
255 ISO2P
Date First Registered:
03/04/2023
Issued on:
11/04/2023
Valid until:
10/04/2026
Awarded to
AVIENT PAKISTAN (PVT) LTD
1A/1, Sector#20, Korangi Industrial Area, Sector 20 Karachi, Pakistan
In recognition of the Organization´s Food Safety Management System which complies with :
ISO 22000:2018
Food Category : I
For the scope of activities described below:
Manufacturing & Processing of Polymer Resins & Master batch
F-3/22/ A 100 Issue date : 06/2022 Version:03
It is mandatory to carry out the surveillance audit on its time.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520-%2520RW%2520Baird%25202015%2520Industrial%2520Conference%2520-%2520November%25202015.pdf
PolyOne Corporation Page 1
PolyOne Investor Presentation
RW Baird 2015 Industrial Conference
November 2015
PolyOne Corporation Page 2
Forward-Looking Statements
In this presentation, statements that are not reported financial results or other historical information are “forward-looking statements” within the meaning of
the Private Securities Litigation Reform Act of 1995.
Platform operating income mix percentage 2005* 2008* 2010* 2013 2014 2015 YTD
Global Color, Additives and Inks $ 4.3 $ 28.1 $ 37.7 $104.0 $124.9 $ 107.9
Global Specialty Engineered Materials 0.4 17.6 49.7 57.2 72.4 63.2
Designed Structures and Solutions - - - 33.4 45.1 12.0
Specialty Platform $ 4.7 $ 45.7 $ 87.4 $194.6 $242.4 $ 183.1
Performance Products and Solutions 75.7 31.3 54.0 56.0 63.1 43.9
Distribution 19.5 28.1 42.0 63.3 68.2 52.4
Joint ventures 91.9 28.6 18.9 - - —
Corporate and eliminations (51.5) (425.1) (27.7) (82.4) (218.6) (59.8)
Operating income (loss) GAAP $140.3 $(291.4) $174.6 $231.5 $155.1 $ 219.6
Less: Corporate operating expense 51.5 425.1 27.7 82.4 218.6 59.8
Operating income excluding Corporate $191.8 $133.7 $202.3 $313.9 $373.7 $ 279.4
Specialty platform operating mix percentage 2% 34% 43% 62% 65% 66%
Adjusted EPS is calculated as follows:
Adjusted EPS 2006Y* 2007Y* 2008Y* 2009Y* 2010Y 2011Y 2012Y 2013Y 2014Y
Net income attributable to
PolyOne common
shareholders $ 130.9 $ 40.9 $ (417.0) $ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0
Joint venture equity earnings,
after tax (68.5) (26.1) (20.8) (19.0) (14.7) (3.7) - - -
Special items, after tax(1) (21.2) 41.4 310.0 (31.0) 15.8 (30.5) 35.7 30.4 101.0
Tax adjustments(2) (30.0) (30.7) 147.2 (44.9) (88.3) (42.3) 0.5 2.2 (10.5)
Adjusted net income $ 11.2 $ 25.5 $ 19.4 $ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5
Diluted shares 92.8 93.1 92.7 93.4 96.0 94.3 89.8 96.5 93.5
Adjusted EPS $ 0.12 $ 0.27 $ 0.21 $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80
2
Adjusted EPS 2011 Q3 2012 Q3 2013 Q3 2014 Q3 2015 Q3
Net income attributable to PolyOne common shareholders $ 16.0 $ 19.4 $ 23.2 $ 32.3 $ 44.5
Special items, after tax(1) 3.1 5.3 10.5 13.2 12.6
Tax adjustments(2) (0.3) 0.1 1.8 (0.1) (9.6)
Adjusted net income $ 18.8 $ 24.8 $ 35.5 $ 45.4 $ 47.5
Diluted shares 94.3 90.2 98.1 93.1 88.4
Adjusted EPS $ 0.20 $ 0.27 $ 0.36 $ 0.49 $ 0.54
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principal or discontinued operations
1) Special items are a non-GAAP financial measure and are used to determine adjusted earnings.
https://www.avient.com/sites/default/files/resources/PDI_Case_Study_-_Medical_Device_0.pdf
CONTACT INFORMATION
Polymer Diagnostics Inc.
33587 Walker Road
Avon Lake, Ohio 44012
United States
+1 800 438 2335
+1 440 930 1644 fax
Polymer Diagnostics Inc. is a contract laboratory with accreditation to ISO/IEC 17025 by the
American Association for Laboratory Accreditation (A2LA) for both chemical and mechanical
capacities.
Americas
U.S. – Avon Lake, Ohio
+ 1 800 438 2335
Asset No. 76593C M Y K PDICaseStudy.indd REMAY 76593
trim: 8.5in x 11in and 8.25in x 11.6875in bleed: 8.75in x 11.9375in Digital/IAM
https://www.avient.com/sites/default/files/2023-01/Disinfectant Resistant Trilliant and Versaflex HC Materials Program Bulletin_0.pdf
Trilliant™ HC high performance formulations were
developed for specific healthcare enclosure needs,
including:
• Chemical resistance to common disinfectants
• UL 94 ratings of 5VA at 3.0, V-0 at 1.5 mm &
V-1 at 0.75 mm
• Retained color aesthetics after chemical
exposure
• Ability to utilize existing PC/PET & COPE tooling
Tested using an adaptation from ASTM D543 for
environmental stress cracking resistance (ESCR),
15 bars of each material were placed into jigs at
1% and 2% strain.
This procedure was completed by placing one
1/2 inch section of rayon gauze at the apex of each
bar, and soaking the gauze with the disinfectant
to saturate the material.
https://www.avient.com/sites/default/files/2020-05/2.-polyone-ir-presenstation-wells-fargo-industrials-conference.pdf
Microsoft PowerPoint - PolyOne Investor Presentation 5.4.20_v8
P E O P LE
P RO D U CT S P LA N E T
P E RF O R MAN C E
JVs Performance Products & Solutions Distribution Specialty
To be the world’s
premier provider of
specialized polymer
materials, services and
solutions
To be the world’s
premier provider of
specialized polymer
materials, services
and sustainable
solutions
2016 2017 2018 2019
Lightweighting Reduced Material Requirements Improved Recyclability
Renewable Energy Applications Eco-conscious Bio-derived Content
Reduced Energy Use VOC Reduction
$275M
$325M
$355M
$410M 14% Total Annual Growth
9% Organic Annual Growth
PolyOne Corporation 33
Adjusted EPS attributable to PolyOne common shareholders is calculated as follows:
2009* 2010* 2011* 2012* 2013* 2014* 2015* 2016** 2017** 2018 2018***
Q1
2019*** 2019
Q1
2020
Net income from continuing operations attributable to PolyOne
common shareholders
Joint venture equity earnings, after tax
Special items, before tax(1)
Special items, tax adjustments(1)
Adjusted net income from continuing operations attributable to
PolyOne common shareholders
$ 106.7 $ 152.5 $ 153.4 $ 53.3 $ 94.0 $ 78.0 $ 144.6 $ 166.4 $ 173.5 $ 161.1 $ 87.7 $ 22.4 $ 75.5 $ 33.1
(19.0) (14.7) (3.7) — — — — — — — — — — —
(48.7) 24.2 (48.1) 55.1 46.3 164.2 87.6 23.8 32.9 59.5 58.7 12.2 61.7 9.6
(27.2) (96.7) (24.7) (18.9) (13.7) (73.7) (58.7) (15.9) (24.8) (25.3) (25.1) (1.2) (5.9) (1.0)
$ 11.8 $ 65.3 $ 76.9 $ 89.5 $ 126.6 $ 168.5 $ 173.5 $ 174.3 $ 181.6 $ 195.3 $ 121.3 $ 33.4 $ 131.3 $ 41.7
Diluted shares 93.4 96.0 94.3 89.8 96.5 93.5 88.7 84.6 82.1 80.4 80.4 78.2 77.7 86.7
Adjusted EPS attributable to PolyOne common shareholders $ 0.13 $ 0.68 $ 0.82 $ 1.00 $ 1.31 $ 1.80 $ 1.96 $ 2.06 $ 2.21 $ 2.43 $ 1.51 $ 0.43 $ 1.69 $ 0.48
* Historical results are shown as presented in prior filings and have not been updated to reflect subsequent changes in accounting principle, discontinued operations or the related resegmentation.
** Pro forma for sale of Designed Structures and Solutions segment (DSS).
*** Pro forma for sale of Performance Products and Solutions segment (PP&S).
Reconciliation to Adjusted EPS Excluding Special Items and Impacts of February 2020 Equity Offering
Three MonthsEnded
March 31, 2020
Net income from continuing operations – GAAP $ 33.1
Special items, after tax(1) 8.6
After tax interest income earned on equity proceeds, included in Interest expense, net (0.7)
Adjusted net income excluding special items and impact of interest income on equity proceeds $ 41.0
Diluted weighted-average shares used to compute earnings per common share 86.7
Weighted-average impact of 15.3 million shares issued in February 2020 equity offering (9.3)
Diluted weighted-average shares excluding impact of shares issued in February 2020 equity offering 77.4
Adjusted EPS - excluding special items and the net impact of equity offering $ 0.53
Reconciliation of Non-GAAP Financial Measures (Unaudited)
(Dollars in millions, except per share data)
Senior management uses comparisons of adjusted net income from continuing operations attributable to PolyOne shareholders and diluted adjusted earnings per share (EPS) from continuing
operations attributable to PolyOne shareholders, excluding special items, to assess performance and facilitate comparability of results.
https://www.avient.com/sites/default/files/2021-06/plastisol-storage-handling-technical-bulletin.pdf
If exposed to cold temperatures, it is recommended
that the container of plastisol be stored at room
temperature for 1–2 days before the plastisol is used.
The frequency of
the need for re-mixing will typically vary between
1 week and 1 month.
https://www.avient.com/sites/default/files/2020-07/sem-w-c-solutions-for-optical-fiber-cable-product-bulletin-a4.pdf
KEY CHARACTERISTICS
• Faster processing speeds (up to 1,000
m/min) at low wall thickness (100 µm)
• Increased chemical resistance
• Lower gel migration
• ECCOH 6153 UV - optimized for Teroson
• ECCOH 6154 UV - optimized for Unigel
• High color rendition and compatibility with
Avient masterbatch
• High UV resistance
• Very low shrinkage
MARKET & APPLICATIONS
Optical Fiber Cables including:
• Stranded loose tubes – gel-filled/dry
• Micro-modules
• Tight buffer applications – gel-filled/dry
STANDARD COMPLIANCE
• IEC 60794
• NF XP C93-850-1-1:2020
• EN 50289-4-17:2016
• ISO 4892:2016
• ST/CNET/5843 (1998)
PRODUCT BULLETIN
GEL MIGRATION PERFORMANCE
ECCOH LSFOH 6153/6154 UV grades offer greater gel migration performance compared to alternative
ECCOH grades.
Gel migration is measured using a quantitative internal method
* 6151 can be supplied with UV protection
* Values concluded from the simulation of materials rheological data and modelling standard extrusion tooling
Pressure: can affect extruder performance, higher pressure gives a lower output at the same rpm
Shear rate: has a relation with self-cleaning of the walls and mixing conditions
Stress: can affect the surface of the product, less stress gives a better surface aspect
MIGRATION OF GEL COMPOUND
Gel Compound ECCOH™ 6151* ECCOH™ 6153 UV ECCOH™ 6154 UV
Unigel Average Good Excellent
Teroson Average Excellent Good
Itcogel Average Good Excellent
ECCOH™ 6151 ECCOH™ 6153 UV ECCOH™ 6154 UV
∆P (bars) 101 63 60
Shear Rate (1/s) 9 9 9
Stress (kPa) 127 79 75
Application example:
Gel-filled stranded loose tube optical fiber cable
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2021-05/avient-responsible-care-ehs-s-policies-2021.pdf
Bob Patterson
Chairman, President, and CEO
August 1, 2020
ENVIRONMENTAL POLICY
Avient Corporation conducts its operations in an environmentally
responsible manner that is protective of the communities in which we
operate.
Bob Patterson
Chairman, President, and CEO
August 1, 2020
SAFETY & HEALTH POLICY
Avient Corporation believes safety and health are the highest corporate
priority.
Bob Patterson
Chairman, President, and CEO
August 1, 2020
Product Stewardship Policy
Product Stewardship plays a significant role in Avient’s sustainable and
ethical business practices.
https://www.avient.com/sites/default/files/2022-09/Cesa Aversive Product Bulletin.pdf
Reference Product Name Carrier
CC10087477BG 87477 EVA Anti-Rat Masterbatch EVA
CC10107079BG 107079 EVA Anti-Termite Masterbatch EVA
CC10125842BG 5842 EVA Multi-Repel Masterbatch EVA
VALUE SOLUTION
The European Union adopted Guidelines in 2015
establishing that masterbatches with biocidal
function needed to be authorized for use in
European Union.1 As such, masterbatch products
containing aversive or repellent substances are
considered as a biocidal product.2 Indeed, deterring
harmful organisms is a biocidal function.
TECHNOLOGY BENEFITS
• Helps provide long term cable protection against
rats and termites
• Enables manufacturers and cable users to be
compliant with EU Regulations
• Easy to use, direct incorporation in the jacket,
no need for additional layer to protect the cable
• Helps avoid unplanned service breakdowns
with associated high repair costs
1 CA-Sept15-Doc.6.2- Final
2 A masterbatch should be regarded as a biocidal product if it is has a biocidal function.
In accordance with Article 3(1)(a) of
Regulation (EU) No 528/2012, destroying, deterring, rendering harmless, preventing the action of, or otherwise exerting a controlling
effect on any harmful organism is a biocidal function.